Pharma’s Next Big Shift: BCG & IPSO Chart India’s CRDMO Path to a $25 Billion Global Opportunity

Written by

in

https://www.prittleprattlenews.com/health/crdmo/

antibody drug conjugates india

Wed, 26 Feb 2025 11:11:00 +0000

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *